Skip to content

Clinical trials

Completed Phase 2 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Status: Completed Clear all

176 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20026
20033
20044
20056
20068
20079
20085
20099
20104
20117
201210
20138
201412
201510
201610
20176
20189
20195
20209
20216
20228
20234
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed176

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
National Eye Institute (NEI)4
GlaxoSmithKline3
Indiana University3
National Heart, Lung, and Blood Institute (NHLBI)3
National Institute of Allergy and Infectious Diseases (NIAID)3
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)3
Novartis Pharmaceuticals3
Apsen Farmaceutica S.A.2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation176
Pain15
Cardiovascular Diseases11
Atherosclerosis9
Coronary Artery Disease9
Arthritis, Rheumatoid7
Diabetes Mellitus7
Asthma6
Crohn Disease6
Diabetes Mellitus, Type 26

Trials

Showing 1 to 25 of 176. Each trial links to its page on Pharma Observatory.

76 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.